ARCHIVES

UHC Expands Risk Models To Include 25 Cancer Variables

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

NCI-Approved Clinical Trials

November 24, 2006

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987